This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Since the discovery of the microbiome, biomedical research has been highly focused on understanding how exactly its interactions within the body contribute to health and disease, and drug development companies are very interested in understanding the potential of microbiome modulating therapies.
The topics covered include:
Major therapeutic areas of drug development including infectious
disease, gastrointestinal disorders, metabolic diseases, dermatological
conditions, and early research in cancers and neurological indications
The time trend in microbiome drug development
The current development landscape, including number of microbiome modulators at each development phase
The top companies investing the most in this research area, and microbiome research collaborations